O	0	9	Autotaxin	Autotaxin	NN	B-NP
O	10	11	(	(	(	O
O	11	14	ATX	ATX	NN	B-NP
O	14	15	)	)	)	O
O	15	16	,	,	,	O
O	17	18	a	a	DT	B-NP
O	19	25	potent	potent	JJ	I-NP
B-Cancer	26	31	tumor	tumor	NN	I-NP
O	32	39	motogen	motogen	NN	I-NP
O	39	40	,	,	,	O
O	41	49	augments	augment	VBZ	B-VP
O	50	58	invasive	invasive	JJ	B-NP
O	59	62	and	and	CC	I-NP
O	63	73	metastatic	metastatic	JJ	I-NP
O	74	83	potential	potential	NN	I-NP
O	84	86	of	of	IN	B-PP
O	87	90	ras	ras	NN	B-NP
O	90	91	-	-	HYPH	B-NP
O	91	102	transformed	transform	VBN	I-NP
B-Cell	103	108	cells	cell	NNS	I-NP
O	108	109	.	.	.	O

O	111	120	Autotaxin	Autotaxin	NN	B-NP
O	121	122	(	(	(	O
O	122	125	ATX	ATX	NN	B-NP
O	125	126	)	)	)	O
O	126	127	,	,	,	O
O	128	130	an	an	DT	B-NP
O	131	134	exo	exo	AFX	I-NP
O	134	135	-	-	HYPH	I-NP
O	135	145	nucleotide	nucleotide	NN	I-NP
O	146	161	pyrophosphatase	pyrophosphatase	NN	I-NP
O	162	165	and	and	CC	I-NP
O	166	183	phosphodiesterase	phosphodiesterase	NN	I-NP
O	183	184	,	,	,	O
O	185	188	was	be	VBD	B-VP
O	189	199	originally	originally	RB	I-VP
O	200	208	isolated	isolate	VBN	I-VP
O	209	211	as	as	IN	B-PP
O	212	213	a	a	DT	B-NP
O	214	220	potent	potent	JJ	I-NP
O	221	231	stimulator	stimulator	NN	I-NP
O	232	234	of	of	IN	B-PP
B-Cell	235	240	tumor	tumor	NN	B-NP
I-Cell	241	245	cell	cell	NN	I-NP
O	246	254	motility	motility	NN	I-NP
O	254	255	.	.	.	O

O	256	258	In	In	IN	B-SBAR
O	259	264	order	order	NN	O
O	265	267	to	to	TO	B-VP
O	268	273	study	study	VB	I-VP
O	274	281	whether	whether	IN	B-SBAR
O	282	285	ATX	ATX	NN	B-NP
O	286	296	expression	expression	NN	I-NP
O	297	304	affects	affect	VBZ	B-VP
O	305	313	motility	motility	NN	B-NP
O	313	314	-	-	HYPH	B-NP
O	314	323	dependent	dependent	JJ	I-NP
O	324	333	processes	process	NNS	I-NP
O	334	338	such	such	JJ	B-PP
O	339	341	as	as	IN	I-PP
O	342	350	invasion	invasion	NN	B-NP
O	351	354	and	and	CC	I-NP
O	355	365	metastasis	metastasis	NN	I-NP
O	365	366	,	,	,	O
O	367	369	we	we	PRP	B-NP
O	370	376	stably	stably	RB	B-ADVP
O	377	388	transfected	transfecte	VBD	B-VP
O	389	393	full	full	JJ	B-NP
O	393	394	-	-	HYPH	I-NP
O	394	400	length	length	NN	I-NP
O	401	404	ATX	ATX	NN	I-NP
O	405	409	cDNA	cDNA	NN	I-NP
O	410	414	into	into	IN	B-PP
O	415	418	two	two	CD	B-NP
O	419	422	non	non	AFX	I-NP
O	422	423	-	-	HYPH	I-NP
O	423	433	expressing	express	VBG	B-VP
B-Cell	434	438	cell	cell	NN	B-NP
I-Cell	439	444	lines	line	NNS	I-NP
O	444	445	,	,	,	O
O	446	454	parental	parental	JJ	B-NP
O	455	458	and	and	CC	I-NP
O	459	462	ras	ras	NN	I-NP
O	462	463	-	-	HYPH	O
O	463	474	transformed	transform	VBN	B-VP
B-Cell	475	481	NIH3T3	NIH3T3	NN	B-NP
I-Cell	482	483	(	(	(	O
I-Cell	483	489	clone7	clone7	NN	B-NP
I-Cell	489	490	)	)	)	O
I-Cell	491	496	cells	cell	NNS	B-NP
O	496	497	.	.	.	O

O	498	501	The	The	DT	B-NP
O	502	508	effect	effect	NN	I-NP
O	509	511	of	of	IN	B-PP
O	512	515	ATX	ATX	NN	B-NP
O	516	525	secretion	secretion	NN	I-NP
O	526	528	on	on	IN	B-PP
O	529	531	in	in	FW	B-NP
O	532	537	vitro	vitro	FW	I-NP
B-Cell	538	542	cell	cell	NN	I-NP
O	543	551	motility	motility	NN	I-NP
O	552	555	was	be	VBD	B-VP
O	556	564	variable	variable	JJ	B-ADJP
O	564	565	.	.	.	O

O	566	569	The	The	DT	B-NP
O	570	573	ras	ras	NN	I-NP
O	573	574	-	-	HYPH	B-VP
O	574	585	transformed	transform	VBN	I-VP
O	585	586	,	,	,	O
O	587	590	ATX	ATX	NN	B-NP
O	590	591	-	-	HYPH	B-VP
O	591	600	secreting	secrete	VBG	B-NP
B-Cell	601	610	subclones	subclone	NNS	I-NP
O	611	614	had	have	VBD	B-VP
O	615	623	enhanced	enhance	VBN	I-VP
O	624	632	motility	motility	NN	B-NP
O	633	635	to	to	TO	B-PP
O	636	639	ATX	ATX	NN	B-NP
O	640	642	as	as	IN	B-PP
O	643	658	chemoattractant	chemoattractant	NN	B-NP
O	658	659	,	,	,	O
O	660	663	but	but	CC	O
O	664	669	there	there	EX	B-NP
O	670	673	was	be	VBD	B-VP
O	674	680	little	little	JJ	B-NP
O	681	691	difference	difference	NN	I-NP
O	692	694	in	in	IN	B-PP
O	695	698	the	the	DT	B-NP
O	699	707	motility	motility	NN	I-NP
O	708	717	responses	response	NNS	I-NP
O	718	720	of	of	IN	B-PP
B-Cell	721	727	NIH3T3	NIH3T3	NN	B-NP
I-Cell	728	733	cells	cell	NNS	I-NP
O	734	745	transfected	transfecte	VBN	B-VP
O	746	750	with	with	IN	B-PP
O	751	754	atx	atx	NN	B-NP
O	754	755	,	,	,	O
O	756	758	an	an	DT	B-NP
O	759	767	inactive	inactive	JJ	I-NP
O	768	774	mutant	mutant	JJ	I-NP
O	775	779	gene	gene	NN	I-NP
O	779	780	,	,	,	O
O	781	783	or	or	CC	O
O	784	789	empty	empty	JJ	B-NP
O	790	796	vector	vector	NN	I-NP
O	796	797	.	.	.	O

O	798	800	In	In	IN	B-PP
O	801	811	MatrigelTM	MatrigelTM	NN	B-NP
O	812	820	invasion	invasion	NN	I-NP
O	821	827	assays	assay	NNS	I-NP
O	827	828	,	,	,	O
O	829	832	all	all	DT	B-NP
B-Cell	833	842	subclones	subclone	NNS	I-NP
O	842	843	,	,	,	O
O	844	849	which	which	WDT	B-NP
O	850	858	secreted	secrete	VBD	B-VP
O	859	872	enzymatically	enzymatically	RB	B-NP
O	873	879	active	active	JJ	I-NP
O	880	883	ATX	ATX	NN	I-NP
O	883	884	,	,	,	O
O	885	897	demonstrated	demonstrate	VBD	B-VP
O	898	905	greater	great	JJR	B-NP
O	906	917	spontaneous	spontaneous	JJ	I-NP
O	918	921	and	and	CC	I-NP
O	922	925	ATX	ATX	NN	I-NP
O	925	926	-	-	HYPH	O
O	926	936	stimulated	stimulate	VBN	B-NP
O	937	945	invasion	invasion	NN	I-NP
O	946	950	than	than	IN	B-PP
O	951	962	appropriate	appropriate	JJ	B-NP
O	963	971	controls	control	NNS	I-NP
O	971	972	.	.	.	O

O	973	977	This	This	DT	B-NP
O	978	988	difference	difference	NN	I-NP
O	989	991	in	in	IN	B-PP
O	992	1004	invasiveness	invasiveness	NN	B-NP
O	1005	1008	was	be	VBD	B-VP
O	1009	1012	not	not	RB	I-VP
O	1013	1019	caused	cause	VBN	I-VP
O	1020	1022	by	by	IN	B-PP
O	1023	1034	differences	difference	NNS	B-NP
O	1035	1037	in	in	IN	B-PP
O	1038	1048	gelatinase	gelatinase	NN	B-NP
O	1049	1059	production	production	NN	I-NP
O	1059	1060	,	,	,	O
O	1061	1066	which	which	WDT	B-NP
O	1067	1070	was	be	VBD	B-VP
O	1071	1079	constant	constant	JJ	B-ADJP
O	1080	1086	within	within	IN	B-PP
O	1087	1091	each	each	DT	B-NP
O	1092	1097	group	group	NN	I-NP
O	1098	1100	of	of	IN	B-PP
B-Cell	1101	1114	transfectants	transfectant	NNS	B-NP
O	1114	1115	.	.	.	O

O	1116	1118	In	In	FW	B-NP
O	1119	1123	vivo	vivo	FW	I-NP
O	1124	1131	studies	study	NNS	I-NP
O	1132	1136	with	with	IN	B-PP
O	1137	1144	athymic	athymic	JJ	B-NP
O	1145	1149	nude	nude	JJ	I-NP
O	1150	1154	mice	mouse	NNS	I-NP
O	1155	1167	demonstrated	demonstrate	VBD	B-VP
O	1168	1172	that	that	IN	B-SBAR
O	1173	1182	injection	injection	NN	B-NP
O	1183	1185	of	of	IN	B-PP
O	1186	1189	atx	atx	NN	B-NP
O	1189	1190	-	-	HYPH	B-NP
O	1190	1201	transfected	transfecte	VBN	I-NP
B-Cell	1202	1208	NIH3T3	NIH3T3	NN	I-NP
I-Cell	1209	1214	cells	cell	NNS	I-NP
O	1215	1223	resulted	result	VBD	B-VP
O	1224	1226	in	in	IN	B-PP
O	1227	1228	a	a	DT	B-NP
O	1229	1233	weak	weak	JJ	I-NP
O	1234	1245	tumorigenic	tumorigenic	JJ	I-NP
O	1246	1254	capacity	capacity	NN	I-NP
O	1255	1259	with	with	IN	B-PP
O	1260	1263	few	few	JJ	B-NP
O	1264	1276	experimental	experimental	JJ	I-NP
B-Cancer	1277	1287	metastases	metastasis	NNS	I-NP
O	1287	1288	.	.	.	O

O	1289	1300	Combination	Combination	NN	B-NP
O	1301	1303	of	of	IN	B-PP
O	1304	1307	ATX	ATX	NN	B-NP
O	1308	1318	expression	expression	NN	I-NP
O	1319	1323	with	with	IN	B-PP
O	1324	1327	ras	ras	NN	B-NP
O	1328	1342	transformation	transformation	NN	I-NP
O	1343	1351	produced	produce	VBD	B-VP
B-Cell	1352	1357	cells	cell	NNS	B-NP
O	1358	1362	with	with	IN	B-PP
O	1363	1370	greatly	greatly	RB	B-NP
O	1371	1380	amplified	amplify	VBN	I-NP
O	1381	1394	tumorigenesis	tumorigenesis	NN	I-NP
O	1395	1398	and	and	CC	I-NP
O	1399	1409	metastatic	metastatic	JJ	I-NP
O	1410	1419	potential	potential	NN	I-NP
O	1420	1428	compared	compare	VBN	B-VP
O	1429	1431	to	to	TO	B-PP
O	1432	1435	ras	ras	NN	B-NP
O	1435	1436	-	-	HYPH	B-NP
O	1436	1447	transformed	transform	VBN	I-NP
B-Cell	1448	1456	controls	control	NNS	I-NP
O	1456	1457	.	.	.	O

O	1458	1462	Thus	Thus	RB	B-ADVP
O	1462	1463	,	,	,	O
O	1464	1467	ATX	ATX	NN	B-NP
O	1468	1475	appears	appear	VBZ	B-VP
O	1476	1478	to	to	TO	I-VP
O	1479	1486	augment	augment	VB	I-VP
B-Cell	1487	1495	cellular	cellular	JJ	B-NP
O	1496	1511	characteristics	characteristic	NNS	I-NP
O	1512	1521	necessary	necessary	JJ	B-ADJP
O	1522	1525	for	for	IN	B-PP
B-Cancer	1526	1531	tumor	tumor	NN	B-NP
O	1532	1546	aggressiveness	aggressiveness	NN	I-NP
O	1546	1547	.	.	.	O

